Kerry Levan Blanchard
Plus aucun poste en cours
Fortune : 25 M $ au 30/04/2024
Postes actifs de Kerry Levan Blanchard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CBC Group Co., Ltd. | Corporate Officer/Principal | - | - |
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Directeur/Membre du Conseil | - | - |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | Directeur/Membre du Conseil | - | - |
| Everstar Medicines Shanghai Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Kerry Levan Blanchard
Anciens postes connus de Kerry Levan Blanchard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EVEREST MEDICINES LIMITED | Directeur/Membre du Conseil | 01/02/2020 | 26/08/2022 |
| Directeur Général | 01/02/2020 | 26/08/2022 | |
| INNOVENT BIOLOGICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 | 01/06/2019 |
Lilly China Research & Development Co. Ltd.
 Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Corporate Officer/Principal | 01/01/2000 | 01/12/2017 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | - | 10/05/2017 |
| Louisiana State University | Corporate Officer/Principal | 01/01/1992 | 01/01/1999 |
Formation de Kerry Levan Blanchard
| Indiana University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 7 |
| Etats-Unis | 3 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INNOVENT BIOLOGICS, INC. | Health Technology |
| EVEREST MEDICINES LIMITED | Health Technology |
| Entreprise privées | 6 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| CBC Group Co., Ltd. | |
Everest Medicines II Ltd.
Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Health Technology |
| EverNov Medicines (Zhuhai Hengqin) Co. Ltd. | |
| Everstar Medicines Shanghai Ltd. | |
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The company is based in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- Kerry Levan Blanchard
- Expérience
